Detalhe da pesquisa
1.
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med
; 387(20): 1865-1876, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322837
2.
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med
; 386(19): 1804-1816, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263534
3.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med
; 387(1): 21-34, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704396
4.
Nirmatrelvir/Ritonavir Use and Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-Risk Population With COVID-19: A Matched Cohort Study.
J Infect Dis
; 229(1): 147-154, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37711076
5.
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med
; 385(24): e83, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614327
6.
Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19.
J Infect Dis
; 228(8): 1033-1041, 2023 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260359
7.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061757
8.
Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.
Am J Public Health
; 113(2): 162-165, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480765
9.
Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
Clin Infect Dis
; 75(1): e849-e856, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893812
10.
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
Clin Infect Dis
; 75(1): e579-e584, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245940
11.
Real-World Effectiveness of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
Clin Infect Dis
; 75(1): e617-e622, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139175
12.
Relative Vaccine Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine Booster Dose Against the Omicron Variant.
Clin Infect Dis
; 75(12): 2161-2168, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511586
13.
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
Clin Infect Dis
; 75(1): e361-e367, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404391
14.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Clin Infect Dis
; 75(1): e1188-e1191, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657152
15.
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
Ann Intern Med
; 174(10): 1404-1408, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34280332
16.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis
; 73(7): e1830-e1840, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315061
17.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis
; 27(5): 1343-1352, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900174
18.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
PLoS Med
; 18(12): e1003879, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914711
19.
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med
; 388(7): 665-667, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652342
20.
Natural history of hepatitis C virus infection in a large national seroconversion cohort in the direct-acting antiviral agent era: Results from ERCHIVES.
J Viral Hepat
; 28(6): 916-924, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763947